ANDA 71126, held by Duramed Pharmaceuticals (Barr). Hydrochlorothiazide; Propranolol Hydrochloride.
As of Nov 22, 2026, ANDA 71126 (Propranolol Hydrochloride & Hydrochlorothiazide), held by Duramed Pharmaceuticals (Barr), was first approved by FDA on Mar 2, 1987, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 2, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propranolol Hydrochloride & Hydrochlorothiazide25MG;40MG · tablet;oral | Hydrochlorothiazide; Propranolol Hydrochloride | Discontinued |
| May 9, 1989 | Supplement 6Labeling | Approved | None posted |
| Apr 6, 1989 | Supplement 5Labeling | Approved | None posted |
| May 25, 1988 | Supplement 3Labeling | Approved | None posted |
| Mar 2, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters